Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion type Assertion NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_head.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion evidence source_evidence_literature NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion SIO_000772 7935401 NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion wasDerivedFrom befree-20150227 NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion wasGeneratedBy ECO_0000203 NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.